{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T10:31:22Z","timestamp":1788690682179,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Stomatology, Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jormas.2017.12.009","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T13:21:01Z","timestamp":1515417661000},"page":"177-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Duration of treatment with bisphosphonates at the time of osteonecrosis of the jaw onset in patients with rheumatoid arthritis. Review"],"prefix":"10.1016","volume":"119","author":[{"given":"H.","family":"Compain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Berquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.-S.","family":"Loison-Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Ahossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Zwetyenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl\u00a03","key":"10.1016\/j.jormas.2017.12.009_bib0195","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1186\/ar578","article-title":"Epidemiology and genetics of rheumatoid arthritis","volume":"4","author":"Silman","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.jormas.2017.12.009_bib0200","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.5037\/jomr.2016.7305","article-title":"General diseases influence on peri-implantitis development: a systematic review","volume":"7","author":"Guobis","year":"2016","journal-title":"J Oral Maxillofac Res"},{"key":"10.1016\/j.jormas.2017.12.009_bib0205","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12891-016-1038-3","article-title":"The challenging interplay between rheumatoid arthritis, ageing and comorbidities","volume":"17","author":"van Onna","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jormas.2017.12.009_bib0210","unstructured":"Haute Autorit\u00e9 de sant\u00e9. Haute Autorit\u00e9 de sant\u00e9 \u2013 Les m\u00e9dicaments de l\u2019ost\u00e9oporose \u2013 Fiche BUM 2014. http:\/\/www.has-sante.fr\/portail\/jcms\/c_1751307\/fr\/les-medicaments-de-losteoporose-fiche-bum (accessed March 27, 2017)."},{"key":"10.1016\/j.jormas.2017.12.009_bib0215","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw \u2013 2014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jormas.2017.12.009_bib0220","unstructured":"SFSCMFCO. Implantologie et bisphosphonates \u2013 Recommandations de Bonne Pratique 2012. http:\/\/www.sfscmfco.fr\/recommandations-de-bonne-pratique-2\/ (accessed March 27, 2017)."},{"key":"10.1016\/j.jormas.2017.12.009_bib0225","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/01.id.0000247855.75691.03","article-title":"Medical contraindications to implant therapy: part I: absolute contraindications","volume":"15","author":"Hwang","year":"2006","journal-title":"Implant Dent"},{"key":"10.1016\/j.jormas.2017.12.009_bib0230","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/ID.0b013e31803276c8","article-title":"Medical contraindications to implant therapy: part II: relative contraindications","volume":"16","author":"Hwang","year":"2007","journal-title":"Implant Dent"},{"key":"10.1016\/j.jormas.2017.12.009_bib0235","first-page":"70","article-title":"Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population","volume":"35","author":"de Pablo","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jormas.2017.12.009_bib0240","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2209\/tdcpublication.54.117","article-title":"Bisphosphonate-related osteonecrosis of jaw (BRONJ) in Japanese population: a case series of 13 patients at our clinic","volume":"54","author":"Nomura","year":"2013","journal-title":"Bull Tokyo Dent Coll"},{"key":"10.1016\/j.jormas.2017.12.009_bib0245","doi-asserted-by":"crossref","first-page":"E723","DOI":"10.1210\/jc.2012-4144","article-title":"A typical femoral fractures shortly after osteonecrosis of the jaw in a postmenopausal woman taking alendronate for osteoporosis","volume":"98","author":"Chiu","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jormas.2017.12.009_bib0250","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1634\/theoncologist.2009-0115","article-title":"Bisphosphonates and time to osteonecrosis development","volume":"14","author":"Palaska","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.jormas.2017.12.009_bib0255","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00774-016-0763-x","article-title":"Dental treatments, tooth extractions, and osteonecrosis of the jaw in Japanese patients with rheumatoid arthritis: results from the IORRA cohort study","volume":"35","author":"Furuya","year":"2017","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.jormas.2017.12.009_bib0260","doi-asserted-by":"crossref","first-page":"334","DOI":"10.4103\/0253-7613.157137","article-title":"A case of early detection of bisphosphonate-related osteonecrosis of the jaw","volume":"47","author":"Mori","year":"2015","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.jormas.2017.12.009_bib0265","first-page":"1409","article-title":"Bisphosphonate therapy and osteonecrosis of the jaw complicated with a temporal abscess in an elderly woman with rheumatoid arthritis: a case report","volume":"9","author":"Manzon","year":"2014","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.jormas.2017.12.009_bib0270","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.joen.2014.01.035","article-title":"Bisphosphonate-associated osteonecrosis of jaw reoccurrence after methotrexate therapy: a case report","volume":"40","author":"Alsalleeh","year":"2014","journal-title":"J Endod"},{"key":"10.1016\/j.jormas.2017.12.009_bib0275","first-page":"139","article-title":"Osteonecrosis of the jaw in a patient with rheumatoid artritis treated with an oral aminobisphosphonate: a clinical case report","volume":"10","author":"Longato","year":"2013","journal-title":"Clin Cases Miner Bone Metab"},{"key":"10.1016\/j.jormas.2017.12.009_bib0280","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3899\/jrheum.120810","article-title":"Osteonecrosis of the jaw and non-malignant disease: is there an association with rheumatoid arthritis?","volume":"40","author":"Lescaille","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jormas.2017.12.009_bib0285","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/rheumatology\/kes351","article-title":"Fulminant course of osteonecrosis of the jaw in a rheumatoid arthritis patient following oral bisphosphonate intake and biologic therapy","volume":"52","author":"Ebker","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jormas.2017.12.009_bib0290","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1746-160X-8-5","article-title":"Epidemiological aspects of rheumatoid arthritis patients affected by oral bisphosphonate-related osteonecrosis of the jaws","volume":"8","author":"Conte-Neto","year":"2012","journal-title":"Head Face Med"},{"key":"10.1016\/j.jormas.2017.12.009_bib0295","first-page":"384","article-title":"Multiple osteonecrosis of the jaw, oral bisphosphonate therapy and refractory rheumatoid arthritis (pathological fracture associated with ONJ and BP use for osteoporosis)","volume":"26","author":"Grana","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jormas.2017.12.009_bib0300","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/odi.12632","article-title":"Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study","volume":"23","author":"Fung","year":"2017","journal-title":"Oral Dis"},{"key":"10.1016\/j.jormas.2017.12.009_bib0305","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.joms.2016.07.019","article-title":"Osteonecrosis of the jaw in the absence of anti-resorptive or anti-angiogenic exposure: a series of 6 cases","volume":"75","author":"Aghaloo","year":"2017","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jormas.2017.12.009_bib0310","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/adj.12235","article-title":"Methotrexate-related lymphoproliferative disorder arising in the gingiva of a patient with rheumatoid arthritis","volume":"60","author":"Horie","year":"2015","journal-title":"Aust Dent J"},{"key":"10.1016\/j.jormas.2017.12.009_bib0315","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.mehy.2011.08.008","article-title":"Is rheumatoid arthritis a risk factor for oral bisphosphonate-induced osteonecrosis of the jaws?","volume":"77","author":"Conte-Neto","year":"2011","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.jormas.2017.12.009_bib0320","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1034\/j.1600-051x.2000.027004267.x","article-title":"Is there a relationship between rheumatoid arthritis and periodontal disease?","volume":"27","author":"Mercado","year":"2000","journal-title":"J Clin Periodontol"},{"key":"10.1016\/j.jormas.2017.12.009_bib0325","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/odi.12490","article-title":"BRONJ in patients with rheumatoid arthritis: a multicenter case series","volume":"22","author":"Di Fede","year":"2016","journal-title":"Oral Dis"},{"key":"10.1016\/j.jormas.2017.12.009_bib0330","doi-asserted-by":"crossref","first-page":"271","DOI":"10.5125\/jkaoms.2016.42.5.271","article-title":"Diseases having an influence on inhibition of angiogenesis as risk factors of osteonecrosis of the jaw","volume":"42","author":"Paek","year":"2016","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"key":"10.1016\/j.jormas.2017.12.009_bib0335","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.joms.2011.08.033","article-title":"Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes","volume":"70","author":"O\u2019Ryan","year":"2012","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jormas.2017.12.009_bib0340","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jormas.2017.12.009_bib0345","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.bone.2007.01.016","article-title":"A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density","volume":"40","author":"Saag","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.jormas.2017.12.009_bib0350","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bone.2007.03.011","article-title":"Intravenous zoledronic acid 5mg in the treatment of postmenopausal women with low bone density previously treated with alendronate","volume":"41","author":"McClung","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.jormas.2017.12.009_bib0355","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2165\/0002512-200825110-00007","article-title":"Zoledronic acid: a review of its use in the treatment of osteoporosis","volume":"25","author":"Deeks","year":"2008","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jormas.2017.12.009_bib0360","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","article-title":"Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia","volume":"65","author":"Mavrokokki","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jormas.2017.12.009_bib0365","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.joms.2011.02.049","article-title":"Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion","volume":"70","author":"Fitzpatrick","year":"2012","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jormas.2017.12.009_bib0370","first-page":"22","article-title":"Implant prosthodontic rehabilitation of patients with rheumatic disorders: a case series report","volume":"23","author":"Weinlander","year":"2010","journal-title":"Int J Prosthodont"},{"key":"10.1016\/j.jormas.2017.12.009_bib0375","first-page":"587","article-title":"Treatment of a patient with severe osteoporosis and chronic polyarthritis with fixed implant-supported prosthesis: a case report","volume":"14","author":"Eder","year":"1999","journal-title":"Int J Oral Maxillofac Implants"},{"key":"10.1016\/j.jormas.2017.12.009_bib0380","series-title":"Recommandations \u2013 SFCO n. d","author":"SFCO","year":"2012"}],"container-title":["Journal of Stomatology, Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468785518300016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468785518300016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T10:05:03Z","timestamp":1762855503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468785518300016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S2468785518300016"],"URL":"https:\/\/doi.org\/10.1016\/j.jormas.2017.12.009","relation":{},"ISSN":["2468-7855"],"issn-type":[{"value":"2468-7855","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Duration of treatment with bisphosphonates at the time of osteonecrosis of the jaw onset in patients with rheumatoid arthritis. Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Stomatology, Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jormas.2017.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}